Sort
15,273 grants matching “antimicrobial resistance”
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance
$1,984,538George Drusano · Ordway Research Institute, Inc. · N01 · FY2010 · AI
Microbial Pathogenesis and Host Inflammatory Responses
$1,982,756Mark S Smeltzer · Univ Of Arkansas For Med Scis · P20 · FY2012 · GM
Comprehensive Sickle Cell Center
$1,977,867Winfred C Wang · St. Jude Children'S Research Hospital · U54 · FY2006 · HL
Clinical trial of trimethoprim-sulfamethoxazole or chloroquine in adults on ART
$1,977,473Miriam K Laufer · University Of Maryland Baltimore · U01 · FY2013 · AI
Predicting the emergence of antibiotic resistance through multi-omics approaches and Immune System-surveillan
$1,970,805Tim Van Opijnen · Boston College · U01 · FY2016 · AI
COVID-19 Supplement - GH16-006: Conducting Communicable Disease Research in Kenya
$1,970,000M Kariuki Njenga · Washington State University · U01 · FY2019 · GH
Application of Genomic Approaches to Bacterial Pathogenesis and Mechanisms of Antimicrobial Resistance
$1,967,333John Dekker · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection
$1,962,994Michael R Yeaman · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U01 · FY2019 · AI
Innovative technologies to transform antibiotic discovery. Project 3 Rapid Access to Antibiotic Biosynthesis Machinery Using Synthetic Biology
$1,956,885Robert Nicol · Broad Institute, Inc. · U19 · FY2019 · AI
Antimicrobial Oligomers for BioDefense and Emerging Food Borne Infectious Disease
$1,950,792Gregory N. Tew · University Of Massachusetts Amherst · U01 · FY2012 · AI
Starve and Kill: Engineered Antigens Targeting Nutrient Acquisition Pathways Essential for Gonococcal Infection and Disease
$1,950,107Cynthia Nau Cornelissen · Georgia State University · U19 · FY2019 · AI
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection
$1,947,150Michael R Yeaman · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U01 · FY2020 · AI
Colorado Emerging Infections Program
$1,945,646Ken A. Gershman · Colorado State Dept/Pub Hlth & Environmt · U01 · FY2010 · CI
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection
$1,941,212Michael R Yeaman · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U01 · FY2017 · AI
Collectins and Innate Defense against Inhaled Pathogens
$1,938,284Barbara A Seaton · Boston University Medical Campus · P01 · FY2010 · AI
CK20-004, WASHINGTON UNIVERSITY & BJC EPICENTER TO PREVENT HEALTHCARE ASSOCIATED INFECTIONS & ANTIBIOTIC RESISTANCE
$1,932,250Victoria J. Fraser · Washington University · U54 · FY2023 · CK
Clinical Trial of Antimicrobial Skin to treat Diabetic Ulcers
$1,931,207Mary A. Lokuta · Stratatech Corporation · R44 · FY2012 · DK
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery
$1,929,581Eleftherios Mylonakis · Miriam Hospital · P20 · FY2019 · GM
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery
$1,923,357Eleftherios Mylonakis · Miriam Hospital · P20 · FY2018 · GM
Autophagy-Inducting Peptides and Target Identification for Treatment of Viruses
$1,921,640Beth C Levine · Washington University · U19 · FY2016 · AI
Biomolecular Structure and Mechanism, Structure-Based Drug Design
$1,917,394Xinhua Ji · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
University of Cape Town Clinical Trials Unit (UCTCTU)
$1,915,344Linda-Gail Bekker · University Of Cape Town · UM1 · FY2016 · AI
Task C24: Process Optimization and Scale Up of an Antibiotic-Resistant Bacterial Agent
$1,905,868Heidi Schlager · Albany Molecular Research, Inc. · N01 · FY2024 · AI
Targeted Clincial Trials to Reduce the Risk of Antimocribal Resistance
$1,904,405Keith Kaye · Wayne State University · N01 · FY2012 · AI
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery
$1,900,857Eleftherios Mylonakis · Miriam Hospital · P20 · FY2020 · GM